Familial Hyperlipidemia, also known as familial hyperlipoproteinemia, is related to hyperlipoproteinemia, type i and hyperlipoproteinemia, type v. An important gene associated with Familial Hyperlipidemia is APOB (Apolipoprotein B), and among its related pathways/superpathways are Metabolism and Transport of inorganic cations/anions and amino acids/oligopeptides. The drugs Dapagliflozin and Calcium polycarbophil have been mentioned in the context of this disorder. Affiliated tissues include heart and liver, and related phenotypes are Increased free cholesterol and Increased LDL uptake